Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.

scientific article published on 02 February 2017

Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.STEMCR.2017.01.003
P932PMC publication ID5312427
P698PubMed publication ID28162997

P50authorMoustapha KassemQ6926286
Li ChenQ61264635
Jean-Marie DelaisséQ67738373
Basem M. AbdallahQ39754711
Daniel HesselsonQ42580532
P2093author name stringSundeep Khosla
Thomas L Andersen
Yuxi Zhang
Stuart Parsons
Nicholas Ditzel
Abbas Jafari
Diyako Qanie
Benno Postert
Per Kjærsgaard-Andersen
Rigmor Solberg
Harald Thidemann Johansen
P2860cites workMechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulationQ27678659
Stages of embryonic development of the zebrafishQ27860947
Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondinsQ28306140
Asparagine endopeptidase is required for normal kidney physiology and homeostasisQ28507681
Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cellsQ28587171
The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.Q29347247
Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase.Q29347297
Osteoblast mineralization requires beta1 integrin/ICAP-1-dependent fibronectin depositionQ30502880
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorptionQ30773401
Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumainQ34127426
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot studyQ34132522
Novel candidate genes in unstable areas of human atherosclerotic plaques.Q51585538
Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.Q51629480
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.Q52119168
The balance of osteogenic and adipogenic differentiation in human mesenchymal stem cells by matrices that mimic stepwise tissue development.Q52619554
Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.Q53579321
Legumain protein as a potential predictive biomarker for Asian patients with breast carcinoma.Q53633144
Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.Q54050012
Legumain: a biomarker for diagnosis and prognosis of human ovarian cancer.Q54317876
Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.Q64885339
Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresisQ78198089
Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal womenQ79762888
Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrationsQ82550731
Extracellular matrix protein mediated regulation of the osteoblast differentiation of bone marrow derived human mesenchymal stem cellsQ84289455
Legumain expression, activity and secretion are increased during monocyte-to-macrophage differentiation and inhibited by atorvastatinQ85283532
ptk7 mutant zebrafish models of congenital and idiopathic scoliosis implicate dysregulated Wnt signalling in diseaseQ34138284
An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.Q34485526
Expression of legumain correlates with prognosis and metastasis in gastric carcinomaQ34984213
Pharmacological Inhibition of Protein Kinase G1 Enhances Bone Formation by Human Skeletal Stem Cells Through Activation of RhoA-Akt SignalingQ35598732
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Q36095068
Rapid reverse genetic screening using CRISPR in zebrafishQ36341911
Matrix metalloproteinases and tumor metastasisQ36471104
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarctionQ36634299
Human mesenchymal stem cells: from basic biology to clinical applications.Q36996120
A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomasQ37267313
Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.Q37349204
Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interferenceQ37415413
Osteoporosis: social and economic impactQ37770703
The reversal phase of the bone-remodeling cycle: cellular prerequisites for coupling resorption and formationQ38239680
Temporal profiling and pulsed SILAC labeling identify novel secreted proteins during ex vivo osteoblast differentiation of human stromal stem cells.Q38323561
Functional role of asparaginyl endopeptidase ubiquitination by TRAF6 in tumor invasion and metastasisQ39017137
Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.Q40481324
Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinaseQ40784522
Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvatureQ41542474
Structure and mechanism of an aspartimide-dependent peptide ligase in human legumainQ41957539
Decreased biosynthesis of actin and cellular fibronectin during adipose conversion of 3T3-F442A cells. Reorganization of the cytoarchitecture and extracellular matrix fibronectinQ42800495
Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytesQ42820082
Nucleoplasmic calcium regulates cell proliferation through legumainQ42832634
Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysineQ42834581
Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cellsQ43251440
Legumain and cathepsin-L expression in human unstable carotid plaque.Q43293933
Understanding coupling between bone resorption and formation: are reversal cells the missing link?Q43405568
Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragmentQ43755563
The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblastsQ44161706
Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.Q44463026
Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro.Q46292337
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesisQ46673284
Radiographic analysis of zebrafish skeletal defectsQ47074000
Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysisQ47722958
The bradford method for protein quantitationQ47766348
Tracking gene expression during zebrafish osteoblast differentiation.Q48862114
Osteoblast recruitment routes in human cancellous bone remodeling.Q50481118
Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis.Q51274687
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectosteoporosisQ165328
P304page(s)373-386
P577publication date2017-02-02
P1433published inStem Cell ReportsQ27725039
P1476titleLegumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis
P478volume8

Reverse relations

cites work (P2860)
Q64944461Bone Marrow Adipose Tissue and Skeletal Health.
Q92699885Brief Report From the 3rd International Meeting on Bone Marrow Adiposity (BMA 2017)
Q64068044Convergence of TGFβ and BMP signaling in regulating human bone marrow stromal cell differentiation
Q92801341Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation
Q61796570KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment
Q64892923Legumain Promotes Atherosclerotic Vascular Remodeling.
Q64066251Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway
Q91388275Metabolic programming determines the lineage-differentiation fate of murine bone marrow stromal progenitor cells
Q48262427Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains
Q33752135Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors
Q61806983Zebrafish as an Emerging Model for Osteoporosis: A Primary Testing Platform for Screening New Osteo-Active Compounds

Search more.